About AD-CARE, University of Rochester Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at AD-CARE, University of Rochester Medical Center
During the past decade, AD-CARE, University of Rochester Medical Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "AD-CARE, University of Rochester Medical Center" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Athira Pharma" with 2 trials
sponsored, "Genentech, Inc." with 2 trials sponsored, "National Institute on Aging (NIA)" with 2 trials sponsored and "Pfizer"
with 2 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "AD-CARE, University of Rochester Medical Center"
#1 collaborator was "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at AD-CARE, University of Rochester Medical Center
According to Clinical.Site data, the most researched conditions in "AD-CARE, University of Rochester Medical Center" are
"Alzheimer Disease" (5 trials), "Alzheimer's Disease" (3 trials), "Dementia" (1 trials), "Dementia of Alzheimer Type" (1 trials) and "Lupus Nephritis" (1 trials). Many other conditions were trialed in "AD-CARE, University of Rochester Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at AD-CARE, University of Rochester Medical Center
Most popular intervention types in "AD-CARE, University of Rochester Medical Center" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "ATH-1017" (2 trials), "Gantenerumab" (2 trials), "Semorinemab" (2 trials) and "[18F]GTP1" (2 trials). Other intervention names were less common.
Clinical Trials Genders at AD-CARE, University of Rochester Medical Center
The vast majority of trials in "AD-CARE, University of Rochester Medical Center" are
10 trials for "All" genders.
Clinical Trials Status at AD-CARE, University of Rochester Medical Center
Currently, there are NaN active trials in "AD-CARE, University of Rochester Medical Center".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 2 completed trials in AD-CARE, University of Rochester Medical Center,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in AD-CARE, University of Rochester Medical Center, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".